{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:32:24Z","timestamp":1778574744499,"version":"3.51.4"},"reference-count":34,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy","award":["32154\/23\/16.12.2024"],"award-info":[{"award-number":["32154\/23\/16.12.2024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Chronic liver disease (CLD) is a major global health concern, contributing significantly to morbidity and mortality. Cirrhosis and liver cancer are the leading causes of liver-related deaths, with various etiological factors, such as metabolic disorders and alcohol-related and viral hepatitis, driving its global prevalence. Non-invasive biomarkers and scoring systems have emerged as key tools for assessing liver disease severity and differentiating CLD from cirrhosis. This study evaluates biomarkers and non-invasive scores and their utility in distinguishing CLD from cirrhosis. Methods: This retrospective observational study included 250 adult patients hospitalized between January 2021 and December 2023 at Cluj County Emergency Clinical Hospital, Romania. Patients were diagnosed with either cirrhosis or CLD of viral, autoimmune, or primary biliary cholangitis (PBC) etiology. Non-invasive biomarkers, scores, and various hemogram-derived ratios were evaluated. Statistical analysis involved descriptive statistics, comparative tests, and receiver operating characteristic (ROC) curve analysis. Results: Among the 250 patients, 137 had liver cirrhosis (54.8%) and 113 had CLD without cirrhosis (45.2%). Significant differences were observed in laboratory parameters, with cirrhosis patients showing lower hemoglobin, platelet count, and albumin levels alongside higher liver enzymes and INR values. Non-invasive scores such as APRI, FIB-4, and NFS demonstrated higher values in the cirrhosis group, indicating more advanced liver damage. Hemogram-derived ratios, particularly the neutrophil-to-lymphocyte ratio (NLR), were higher in cirrhosis patients. ROC analysis revealed that the Lok index had the highest discriminatory power (AUC 0.89), followed by the King score (AUC 0.864) and the Fibrosis index (AUC 0.856), which effectively distinguished cirrhosis from CLD. Conclusions: This study underscores the utility of non-invasive biomarkers and scoring systems in differentiating CLD from cirrhosis. The Lok index, King score, and Fibrosis index demonstrated excellent diagnostic accuracy, while hemogram-derived ratios, such as NLR, offer insights into systemic inflammation associated with liver disease progression. These findings support the integration of non-invasive markers into clinical practice for improved risk stratification and management of liver diseases.<\/jats:p>","DOI":"10.3390\/jcm14093072","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:49:36Z","timestamp":1745912976000},"page":"3072","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Impact of Non-Invasive Scores and Hemogram-Derived Ratios in Differentiating Chronic Liver Disease from Cirrhosis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-271X","authenticated-orcid":false,"given":"Abdulrahman","family":"Ismaiel","sequence":"first","affiliation":[{"name":"2nd Department of Internal Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evrard","family":"Katell","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400394 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-8622","authenticated-orcid":false,"given":"Daniel-Corneliu","family":"Leucuta","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biostatistics, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-2598","authenticated-orcid":false,"given":"Stefan-Lucian","family":"Popa","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-6265","authenticated-orcid":false,"given":"Cristina Sorina","family":"Catana","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, \u201cIuliu Ha\u0163ieganu\u201d University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan L.","family":"Dumitrascu","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6020-4724","authenticated-orcid":false,"given":"Teodora","family":"Surdea-Blaga","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The Global Burden of Liver Disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: Epidemiology, causes, trends and predictions","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","unstructured":"Sharma, A., and Nagalli, S. (2023, July 03). Chronic Liver Disease, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554597\/."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Trifan, A., Stanciu, C., and Muzica, C. (2023). Natural History of Nonalcoholic Fatty Liver Disease. Essentials of Non-Alcoholic Fatty Liver Disease, Springer.","DOI":"10.1007\/978-3-031-33548-8"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"Pagliaro","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jceh.2022.04.021","article-title":"Overview of Complications in Cirrhosis","volume":"12","author":"Premkumar","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Thanapirom, K., Suksawatamnuay, S., Tanpowpong, N., Chaopathomkul, B., Sriphoosanaphan, S., Thaimai, P., Srisoonthorn, N., Treeprasertsuk, S., and Komolmit, P. (2022). Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: A prospective study. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-08955-x"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.23736\/S0031-0808.20.04171-3","article-title":"Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: Systematic review and meta-analysis","volume":"63","author":"Ismaiel","year":"2021","journal-title":"Panminerva Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Scarlata, G.G.M., Ismaiel, A., Gambardella, M.L., Leucuta, D.C., Luzza, F., Dumitrascu, D.L., and Abenavoli, L. (2024). Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience. Medicina, 60.","DOI":"10.3390\/medicina60111854"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jceh.2012.11.002","article-title":"Model for End-stage Liver Disease","volume":"3","author":"Singal","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3350\/cmh.2013.19.2.105","article-title":"Important predictor of mortality in patients with end-stage liver disease","volume":"19","author":"Kim","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.21037\/atm-20-2444","article-title":"Fibrosis index predicts variceal bleeding and reduces need for nonselective beta-blocker in compensated cirrhosis with initial small esophageal varices without red-color sign","volume":"8","author":"Wang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, K., Tang, S., Liu, C., Ma, J., Cao, X., Yang, X., Zhu, Y., Chen, K., Liu, Y., and Zhang, C. (2024). Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1337241"},{"key":"ref_18","unstructured":"Tsoris, A., and Marlar, C.A. (2023, March 13). Use Of The Child Pugh Score In Liver Disease, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542308\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ciornolutchii, V., Ruta, V.M., Man, A.M., Motoc, N.S., Popa, S.L., Dumitrascu, D.L., Ismaiel, A., and Leucuta, D.C. (2024). Exploring the Role of Hemogram-Derived Ratios and Liver Fibrosis Scores in Pulmonary Fibrosis. Medicina, 60.","DOI":"10.3390\/medicina60101702"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1155\/2009\/591317","article-title":"Abnormal hematological indices in cirrhosis","volume":"23","author":"Qamar","year":"2009","journal-title":"Can. J. Gastroenterol."},{"key":"ref_22","first-page":"285","article-title":"The relationship between lipid profile and severity of liver damage in cirrhotic patients","volume":"10","author":"Ghadir","year":"2010","journal-title":"Hepat. Mon."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","article-title":"Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: A systematic review and meta-analysis","volume":"10","author":"Liguori","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Xuan, Y., Wu, D., Zhang, Q., Yu, Z., Yu, J., and Zhou, D. (2024). Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: Insights from a cross-sectional analysis in the United States. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1457598"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.5604\/01.3001.0012.7190","article-title":"ALBI and PALBI: Novel Scores for Outcome Prediction of Cirrhotic Outpatients Awaiting Liver Transplantation","volume":"17","author":"Chedid","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.23736\/S0026-4806.22.08185-X","article-title":"Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis","volume":"113","author":"Elsayed","year":"2022","journal-title":"Minerva Med."},{"key":"ref_27","first-page":"1","article-title":"Nonalcoholic Fatty Liver Disease: A Literature Review of Epidemiology, Pathophysiology, and Diagnostic Approaches","volume":"6","author":"Jaaouani","year":"2024","journal-title":"Glob. J. Med. Therap."},{"key":"ref_28","first-page":"498","article-title":"Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD","volume":"89","year":"2024","journal-title":"Rev. Gastroenterol. Mex. (Engl. Ed.)"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update. J. Hepatol., 75, 659\u2013689.","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.51821\/85.1.9156","article-title":"GPR, King\u2019s Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients","volume":"85","author":"Ekin","year":"2022","journal-title":"Acta Gastro-Enterol. Belg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100774","DOI":"10.1016\/j.aohep.2022.100774","article-title":"New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD","volume":"28","author":"Torres","year":"2023","journal-title":"Ann. Hepatol."},{"key":"ref_32","first-page":"11","article-title":"Neutrophil to Lymphocyte Ratio (NLR) and its Correlation with Child Turcotte Pugh (CTP) Score in Prediciting Severity of Decompensated Liver Cirrhosis","volume":"70","author":"Sahani","year":"2022","journal-title":"J. Assoc. Physicians India"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yan, C., Zhang, W., Xiao, Y., Sun, Y., Peng, X., and Cai, W. (2024). The predictive role of the platelet-to-lymphocyte ratio for the risk of non-alcoholic fatty liver disease and cirrhosis: A nationwide cross-sectional study. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1376894"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Glisic, T., Popovic, D.D., Lolic, I., Toplicanin, A., Jankovic, K., Dragasevic, S., Aleksic, M., Stjepanovic, M., Oluic, B., and Matovic Zaric, V. (2023). Hematological Indices Are Useful in Predicting Complications of Liver Cirrhosis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144820"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3072\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:24:05Z","timestamp":1760030645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/3072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jcm14093072"],"URL":"https:\/\/doi.org\/10.3390\/jcm14093072","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}